Rehovot, Israel

Michael Menachem Tsoory

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yeda Research and Development Co. Ltd. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Menachem Tsoory: Innovator in Alzheimer's Disease Treatment

Introduction

Michael Menachem Tsoory is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of medical research, particularly in the treatment of Alzheimer's disease. His innovative approach has led to the development of a patent that addresses this critical health issue.

Latest Patents

Michael Menachem Tsoory holds a patent for a method related to treating Alzheimer's disease. This patent represents his commitment to advancing medical science and improving the quality of life for individuals affected by this condition. He has 1 patent to his name, showcasing his innovative contributions to the field.

Career Highlights

Throughout his career, Tsoory has been associated with Yeda Research and Development Company Ltd. This organization is known for its focus on scientific research and development, particularly in the biomedical sector. His work at Yeda has allowed him to collaborate with leading experts in the field.

Collaborations

Michael has worked alongside esteemed colleagues such as Ruth Arnon and Ruth Maron. These collaborations have enriched his research and contributed to the advancement of knowledge in the treatment of Alzheimer's disease.

Conclusion

Michael Menachem Tsoory is a dedicated inventor whose work in treating Alzheimer's disease has the potential to make a significant impact on healthcare. His innovative spirit and collaborative efforts continue to drive progress in this vital area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…